外髂动脉外翻内膜剥脱术治疗TASC II C/D级髂股闭塞性病变所致慢性肢体威胁性缺血
本回顾性研究纳入2015年9月至2020年2月间18例外髂动脉外翻内膜剥脱术(EEEIA),全部用于慢性肢体威胁性缺血且术后感染风险增高、不宜腔内治疗的患者。中位随访1012天(95%CI 119–1365天),730天一期通畅率81%、累积通畅率92%、无截肢生存率80%、总生存率88%,无30天死亡及术后手术感染。结论认为EEEIA是避免使用人工血管时有效、安全的自体血管重建选择。
要点
- EEEIA可作为不宜腔内治疗、需避免人工血管的TASC II C/D级髂股闭塞患者的自体血管重建选择。
- 730天一期通畅率81%、累积通畅率92%、无截肢生存率80%、总生存率88%。
- 本组无30天死亡及术后手术感染,但样本量小、为回顾性单中心研究。
核心结论
- 外髂动脉外翻内膜剥脱术是治疗慢性肢体威胁性缺血合并TASC II C/D级髂股闭塞的有效手术方式,通畅率、无截肢生存率和总生存率良好。
- 在需要避免使用人工血管的病例中,EEEIA可视为有用且安全的选择。
研究设计与样本
- 回顾性研究,2015年9月至2020年2月共实施18例外髂动脉外翻内膜剥脱术(EEEIA)。
- 全部病例均用于慢性肢体威胁性缺血治疗,患者术后手术感染风险增高且不宜腔内治疗。
- 人口学、临床变量和结局取自前瞻性数据库,采用Kaplan-Meier分析估计累积结局时间。
主要发现
- 平均年龄64.8±8.3岁,以男性为主。
- 中位随访1012天(95%CI 119–1365天)。
- 多数为Rutherford 5级(n=13,72.2%),平均踝肱指数0.38±0.22。
- 730天时一期通畅率81%、累积通畅率92%、无截肢生存率80%、总生存率88%。
- 无30天死亡,无术后手术感染。
临床怎么用
- 对慢性肢体威胁性缺血、TASC II C/D级髂股闭塞且不宜腔内治疗、需避免人工血管的患者,可考虑EEEIA作为自体血管重建方式。
- 术后随访可关注通畅率、无截肢生存率和总生存率等结局指标。
局限性
- 回顾性研究,样本量仅18例,为单中心经验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular treatment of iliofemoral occlusive disease is a challenging approach, especially for TransAtlantic Inter-Society C and D lesions. Therefore, the revascularization procedure in such situations is preferably performed by bypass graft surgery with synthetic materials. The purpose of this study is to report the feasibility and mid-term results of eversion endarterectomy of the external iliac artery (EEEIA), as an alternative autologous option. METHODS: Retrospective study with 18 EEEIA performed between September 2015 and February 2020, exclusively for chronic limb-threatening ischemia treatment in patients with increased risk of postoperative surgical infection and inadvisable for endovascular treatment. Demographic, clinical variables and outcomes were collected from a prospective database. The main end points are: amputation-free survival (AFS) and 30-day mortality. Secondary end points include: primary patency (PP), cumulative patency (CP), overall survival (OS), and postoperative surgical complication. Kaplan-Meier analysis was used to estimate cumulative time of outcomes. RESULTS: The mean age was 64.8 ± 8.3 years, with predominance of men. The median follow-up period was 1012 days, 95% confidence interval [119, 1365] days. Most had Rutherford 5 (n = 13, 72.2%) and mean ankle brachial index was 0.38 ± 0.22. The PP, CP, AFS, and OS in 730 days were 81%, 92%, 80%, and 88%, respectively. There was no 30-day mortality or postoperative surgical infection. CONCLUSIONS: Iliofemoral reconstruction through EEEIA is an effective surgical procedure with good patency rates, AFS and OS. In addition, it can be considered an useful and safe option, especially in cases in which a prosthesis should be avoided.
引用
- Giusti JCG, Cury MVM, Rossi FH, et al. Eversion Endarterectomy of the External Iliac Artery in Treating Chronic Limb-Threatening Ischemia in TASC II C and D Iliofemoral Occlusive Disease. Ann Vasc Surg. 2021. PMID: 33556512. doi:10.1016/j.avsg.2021.01.098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。